The Center for Integration of Medicine & Innovative Technology (CMIT) and Sensor Technology-Devices (ST+D) are collaborating on a monitoring device. ST+D transferred a prototype of a miniaturized wearable wireless device to monitor vital signs in traditionally unmonitored low-acuity settings to CMIT.
ST&D is a Belfast spin-out of the University of Ulster with experience in developing medical sensors and wireless systems to monitor patients’ vital sign. The company recently teamed with CMIT investigators led by Dr. Nat Sims, of Massachusetts General Hospital.
ST-D and CMIT are developing the device to provide information on heart, respiration, temperature, and movement. The device will use existing hospital wireless networks to immediately notify clinical teams if there is a change in the patient’s health. The device will be called “Guardian Aingeal” which is the Irish word for angel.
Members forming the consortium include Beth Israel Deaconess Medical, Center, Boston Medical Center, Boston University, Brigham and Women’s Hospital, the Charles Stark Draper Laboratory, Children’s Hospital Boston, Harvard Medical School, Massachusetts General Hospital, MIT, Newton-Wellesley Hospital, Partners HealthCare, and VA Boston Healthcare System.
ST&D’s latest funding round has been led by Belfast-based Clarendon fund managers and supported by existing investors including Enterprise Equity. Wellcome Trust has also provided research funding plus Invest Northern Ireland supports the initiative with CIMIT with financial support.
